---
title: "BAKER / TISCH CAPITAL (GP), LLC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f990f17a-cce2-5634-bd2e-453124e46759
json: https://whiteintel.dev/api/public/dossier/f990f17a-cce2-5634-bd2e-453124e46759
identifier: sec:0001244392
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BAKER / TISCH CAPITAL (GP), LLC

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001244392`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f990f17a-cce2-5634-bd2e-453124e46759  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f990f17a-cce2-5634-bd2e-453124e46759  

## Ownership & control

### Holdings / subsidiaries

- **VIROPHARMA INC** (tenpercentowner) — https://whiteintel.dev/entity/e244d635-37f3-5b82-8697-589e79914154
- **SEAGEN INC.** (director) — https://whiteintel.dev/entity/c5825089-63d5-5f88-83d5-fd3fc54d96d0
- **SEAGEN INC.** (tenpercentowner) — https://whiteintel.dev/entity/c5825089-63d5-5f88-83d5-fd3fc54d96d0
- **ADOLOR CORP** (tenpercentowner) — https://whiteintel.dev/entity/5a9fb915-ed75-5410-8809-88dae879266c
- **SYNAGEVA BIOPHARMA CORP** (director) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **SYNAGEVA BIOPHARMA CORP** (tenpercentowner) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **HERON THERAPEUTICS, INC. /DE/** (tenpercentowner) — https://whiteintel.dev/entity/c1e81bd7-087e-5277-a7a4-ace13d8fe6da
- **AUXILIUM PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/352b9eca-23d8-5e62-bd3e-cb392e7e642c
- **INCYTE CORP** (tenpercentowner) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **INCYTE CORP** (director) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **GENOMIC HEALTH INC** (tenpercentowner) — https://whiteintel.dev/entity/2499a431-37e6-5c7a-a147-eaa00d248197
- **BIOCRYST PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/4c2abb17-afd7-5282-930a-5a120a05fb83
- **GENOMIC HEALTH INC** (director) — https://whiteintel.dev/entity/2499a431-37e6-5c7a-a147-eaa00d248197
- **ALLOS THERAPEUTICS** (tenpercentowner) — https://whiteintel.dev/entity/4e00b74d-beb6-5d0f-ba45-4ae0f366fc77
- **ARDEA BIOSCIENCES, INC./DE** (tenpercentowner) — https://whiteintel.dev/entity/9add041c-7d78-510d-bded-b9d2b378f844
- **NEUROGEN CORP** (director) — https://whiteintel.dev/entity/c8486ba7-ad25-5aea-8a1c-de4d59b0404a
- **NEUROGEN CORP** (tenpercentowner) — https://whiteintel.dev/entity/c8486ba7-ad25-5aea-8a1c-de4d59b0404a
- **ALTEON INC /DE** (tenpercentowner) — https://whiteintel.dev/entity/24eee9ce-bb3a-5c8f-9879-1f94fc3cacfc

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BAKER / TISCH CAPITAL (GP), LLC**. Human view: https://whiteintel.dev/entity/f990f17a-cce2-5634-bd2e-453124e46759 · Structured JSON: https://whiteintel.dev/api/public/dossier/f990f17a-cce2-5634-bd2e-453124e46759._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._